Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methamphetamine fMRI Reward Function Study
NCT04642820Phase 1Completed
- Sponsor
- University of Chicago
- Start
- Nov 2020
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of methamphetamine (2 arms), sponsored by University of Chicago. Primary endpoint: Change in Subjective Effects as Assessed by Score on 'Feel Drug', 'Feel High', 'Like Drug', and 'Want More' Sub-scales of Drug Effects Questionnaire (DEQ) at Day 3. Started Nov 2020; status: completed.
02
Drugs
methamphetamine
Beyond the preview
Go deeper on NCT04642820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04642820.